Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia

GSK Investigational Site, Staten Island

GSK Investigational Site, Maitland

GSK Investigational Site, Winter Park

GSK Investigational Site, Coral Springs

GSK Investigational Site, Miami

GSK Investigational Site, North Miami

GSK Investigational Site, Nashville

GSK Investigational Site, Indianapolis

GSK Investigational Site, Oak Brook

GSK Investigational Site, Niles

GSK Investigational Site, Little Rock

GSK Investigational Site, Bellaire

GSK Investigational Site, San Antonio

GSK Investigational Site, Los Angeles

GSK Investigational Site, Pico Rivera

GSK Investigational Site, Glendale

GSK Investigational Site, Sherman Oaks

GSK Investigational Site, San Diego

GSK Investigational Site, Garden Grove

GSK Investigational Site, Indianapolis

GSK Investigational Site, Madison

GSK Investigational Site, Edmonton

GSK Investigational Site, Edmonton

GSK Investigational Site, Kelowna

GSK Investigational Site, Winnipeg

GSK Investigational Site, Miramichi

GSK Investigational Site, Dartmouth

GSK Investigational Site, Sydney

GSK Investigational Site, Burlington

GSK Investigational Site, Greater Sudbury

GSK Investigational Site, London

GSK Investigational Site, Mississauga

GSK Investigational Site, Toronto

GSK Investigational Site, Windsor

GSK Investigational Site, Bedford

GSK Investigational Site, Cambridge

GSK Investigational Site, Glasgow

GSK Investigational Site, Coventry

GSK Investigational Site, Hull